Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

721
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

562
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

805
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

611
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
611
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

1.3K
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diuretic Resistance Risk and the Efficacy of Torsemide vs Furosemide: A Post-Hoc Analysis of the TRANSFORM-HF Trial.

European journal of heart failure·2026
Same author

Association of Guideline-Directed Medical Therapy for Heart Failure and Major Amputation Rates in Patients With Chronic Limb-Threatening Ischemia and Concomitant Heart Failure.

The American journal of cardiology·2026
Same author

Surgical Risk and Revascularization-An Update.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Discordance of Aortic Valve Area Indexed to Actual and Ideal Body Surface Area in Aortic Stenosis.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HF.

medRxiv : the preprint server for health sciences·2026
Same author

Management of Ischemic Heart Disease in Patients With Heart Failure: JACC: Heart Failure Position Statement.

JACC. Heart failure·2025
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.6K

Revascularization in severe left ventricular dysfunction.

Eric J Velazquez1, Robert O Bonow2

  • 1Department of Medicine-Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

Journal of the American College of Cardiology
|February 14, 2015
PubMed
Summary
This summary is machine-generated.

For high-risk heart failure patients with reduced ejection fraction, surgical interventions like revascularization may improve long-term survival. Risks must be weighed against potential benefits in this complex patient group.

Keywords:
coronary artery bypass graftingcoronary artery diseaseheart failure

More Related Videos

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.5K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

Related Experiment Videos

Last Updated: Apr 17, 2026

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
10:18

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

3.6K
Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA

Published on: April 24, 2017

19.5K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Heart Failure Research

Background:

  • Patients with heart failure and reduced ejection fraction (HFrEF), particularly those with ischemic cardiomyopathy and severe left ventricular systolic dysfunction (ejection fraction ≤35%), represent a high-risk group.
  • Current management relies on guideline-directed medical therapy and device therapy for select individuals.

Purpose of the Study:

  • To review the evolving evidence on surgical interventions for high-risk patients with HFrEF.
  • To evaluate the role of surgical revascularization, surgical ventricular reconstruction, and mitral valve surgery in this population.

Main Methods:

  • Review of current literature and evolving data on surgical treatments for HFrEF.
  • Analysis of risk-benefit profiles for surgical interventions in high-risk patients.

Main Results:

  • Surgical revascularization may enhance survival and quality of life, especially in patients with extensive multivessel disease and severe left ventricular dysfunction.
  • These high-risk patients face the greatest short-term mortality risk from coronary artery bypass graft surgery.
  • Balancing short-term surgical risks with long-term benefits is crucial for treatment decisions.

Conclusions:

  • Surgical options, including revascularization and ventricular reconstruction, offer potential benefits for select high-risk HFrEF patients.
  • Careful patient selection and risk stratification are essential for optimizing outcomes.
  • Further research is needed to refine the role of these surgical approaches in managing complex HFrEF.